Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes.

Reigadas S, Marcelin AG, Houssaïni A, Yerly S, Descamps D, Plantier JC, Ruffault A, Amiel C, Trabaud MA, Flandre P, Fleury H, Masquelier B; ANRS AC11 Resistance Study Group.

J Antimicrob Chemother. 2013 Apr;68(4):969-72. doi: 10.1093/jac/dks474. Epub 2012 Nov 25. No abstract available.

PMID:
23184711
[PubMed - indexed for MEDLINE]
Free Article
2.

Appearance of Drug Resistance-Associated Mutations in Human Immunodeficiency Virus Type 1 CRF01_AE Integrase Derived from Drug-Naive Thai Patients.

Isarangkura-Na-Ayuthaya P, Kaewnoo W, Auwanit W, de Silva UC, Ikuta K, Sawanpanyalert P, Kameoka M.

AIDS Res Hum Retroviruses. 2010 Dec;26(12):1341-3. doi: 10.1089/aid.2010.0140. Epub 2010 Sep 13.

PMID:
20836708
[PubMed - indexed for MEDLINE]
3.

HIV-1 integrase sequence variability in antiretroviral naïve patients and in triple-class experienced patients subsequently treated with raltegravir.

Varghese V, Liu TF, Rhee SY, Libiran P, Trevino C, Fessel WJ, Shafer RW.

AIDS Res Hum Retroviruses. 2010 Dec;26(12):1323-6. doi: 10.1089/aid.2010.0123. Epub 2010 Oct 21.

PMID:
20961278
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Minimal sequence variability of the region of HIV-1 integrase targeted by the Abbott RealTime HIV-1 viral load assay in clinical specimens with reduced susceptibility to raltegravir.

Young TP, Napolitano LA, Paquet AC, Parkin NT, Fransen S, Trinh R, Haddad M, Hackett J Jr, Cloherty GA.

J Virol Methods. 2013 Nov;193(2):693-6. doi: 10.1016/j.jviromet.2013.07.028. Epub 2013 Jul 25.

PMID:
23892128
[PubMed - indexed for MEDLINE]
5.

Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection.

Garrido C, Geretti AM, Zahonero N, Booth C, Strang A, Soriano V, De Mendoza C.

J Antimicrob Chemother. 2010 Feb;65(2):320-6. doi: 10.1093/jac/dkp423. Epub 2009 Dec 9.

PMID:
20007331
[PubMed - indexed for MEDLINE]
Free Article
6.

The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype.

Malet I, Fourati S, Charpentier C, Morand-Joubert L, Armenia D, Wirden M, Sayon S, Van Houtte M, Ceccherini-Silberstein F, Brun-Vézinet F, Perno CF, Descamps D, Capt A, Calvez V, Marcelin AG.

J Antimicrob Chemother. 2011 Dec;66(12):2827-30. doi: 10.1093/jac/dkr389. Epub 2011 Sep 19.

PMID:
21933786
[PubMed - indexed for MEDLINE]
Free Article
7.

Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors.

Ceccherini-Silberstein F, Malet I, Fabeni L, Dimonte S, Svicher V, D'Arrigo R, Artese A, Costa G, Bono S, Alcaro S, Monforte Ad, Katlama C, Calvez V, Antinori A, Marcelin AG, Perno CF.

J Antimicrob Chemother. 2010 Nov;65(11):2305-18. doi: 10.1093/jac/dkq326. Epub 2010 Sep 3.

PMID:
20817922
[PubMed - indexed for MEDLINE]
Free Article
8.

HIV type 1 integrase polymorphisms in treatment-naive and treatment-experienced HIV type 1-infected patients in Thailand where HIV type 1 subtype A/E predominates.

Phuphuakrat A, Pasomsub E, Kiertiburanakul S, Chantratita W, Sungkanuparph S.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):937-43. doi: 10.1089/AID.2011.0139. Epub 2011 Nov 22.

PMID:
21970343
[PubMed - indexed for MEDLINE]
9.

Potential drug resistance polymorphisms in the integrase gene of HIV type 1 subtype A.

Herring BL, Cunningham AL, Dwyer DE.

AIDS Res Hum Retroviruses. 2004 Sep;20(9):1010-4.

PMID:
15585088
[PubMed - indexed for MEDLINE]
10.

Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients.

Malet I, Wirden M, Fourati S, Armenia D, Masquelier B, Fabeni L, Sayon S, Katlama C, Perno CF, Calvez V, Marcelin AG, Ceccherini-Silberstein F.

J Antimicrob Chemother. 2011 Jul;66(7):1481-3. doi: 10.1093/jac/dkr152. Epub 2011 Apr 7.

PMID:
21474479
[PubMed - indexed for MEDLINE]
Free Article
11.

Susceptibility to etravirine of HIV type 1 subtype C isolates from nevirapine/efavirenz-experienced patients: comparative interpretation of ANRS and STANFORD algorithms.

Anquetil D, Deshpande A, Zongo D, Le Bihan L, Pinson PR, Fleury HJ.

AIDS Res Hum Retroviruses. 2012 Dec;28(12):1793-7. doi: 10.1089/AID.2012.0060. Epub 2012 Jun 1.

PMID:
22519709
[PubMed - indexed for MEDLINE]
12.

Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes.

Maïga AI, Malet I, Soulie C, Derache A, Koita V, Amellal B, Tchertanov L, Delelis O, Morand-Joubert L, Mouscadet JF, Murphy R, Cissé M, Katlama C, Calvez V, Marcelin AG.

Antivir Ther. 2009;14(1):123-9.

PMID:
19320246
[PubMed - indexed for MEDLINE]
13.

Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption.

Canducci F, Barda B, Ceresola E, Spagnuolo V, Sampaolo M, Boeri E, Nozza S, Cossarin F, Galli A, Gianotti N, Castagna A, Lazzarin A, Clementi M.

Clin Microbiol Infect. 2011 Jun;17(6):928-34. doi: 10.1111/j.1469-0691.2010.03375.x. Epub 2010 Nov 5.

PMID:
20854427
[PubMed - indexed for MEDLINE]
14.

Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors.

Brenner BG, Lowe M, Moisi D, Hardy I, Gagnon S, Charest H, Baril JG, Wainberg MA, Roger M.

J Med Virol. 2011 May;83(5):751-9. doi: 10.1002/jmv.22047. Epub 2011 Feb 25.

PMID:
21360548
[PubMed - indexed for MEDLINE]
15.

HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients.

Piralla A, Paolucci S, Gulminetti R, Comolli G, Baldanti F.

Virol J. 2011 Mar 31;8:149. doi: 10.1186/1743-422X-8-149.

PMID:
21453487
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure.

van Hal SJ, Herring B, Deris Z, Wang B, Saksena NK, Dwyer DE.

Retrovirology. 2009 Feb 9;6:12. doi: 10.1186/1742-4690-6-12.

PMID:
19203393
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity.

Fun A, Van Baelen K, van Lelyveld SF, Schipper PJ, Stuyver LJ, Wensing AM, Nijhuis M.

J Antimicrob Chemother. 2010 Nov;65(11):2300-4. doi: 10.1093/jac/dkq319. Epub 2010 Aug 24.

PMID:
20736234
[PubMed - indexed for MEDLINE]
Free Article
18.

HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays.

Bar-Magen T, Donahue DA, McDonough EI, Kuhl BD, Faltenbacher VH, Xu H, Michaud V, Sloan RD, Wainberg MA.

AIDS. 2010 Sep 10;24(14):2171-9. doi: 10.1097/QAD.0b013e32833cf265.

PMID:
20647908
[PubMed - indexed for MEDLINE]
19.

Performance of the Abbott RealTime HIV-1 viral load assay is not impacted by integrase inhibitor resistance-associated mutations.

Young TP, Cloherty G, Fransen S, Napolitano L, Swanson P, Herman C, Parkin NT, Hackett J Jr.

J Clin Microbiol. 2011 Apr;49(4):1631-4. doi: 10.1128/JCM.02253-10. Epub 2011 Feb 2.

PMID:
21289145
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Genetic diversity on the integrase region of the pol gene among HIV type 1-infected patients naive for integrase inhibitors in São Paulo City, Brazil.

Arruda LB, Fonseca LA, Duarte AJ, Casseb J.

AIDS Res Hum Retroviruses. 2010 Jan;26(1):105-7. doi: 10.1089/aid.2009.0179.

PMID:
20055590
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk